Bi‐Feng Liu

机构：Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology · ORCID：0000-0002-2135-0873

发表论文 324 篇 · 总被引 10675 次 · h-index 56

代表论文

• Recent advances in centrifugal microfluidics for point-of-care testing (2025 · Lab on a Chip · 被引 57)
• Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 46)
• Fully Integrated Centrifugal Microfluidics for Rapid Exosome Isolation, Glycan Analysis, and Point-of-Care Diagnosis (2025 · ACS Nano · 被引 46)
• Deep Learning‐Enhanced Hand‐Driven Microfluidic Chip for Multiplexed Nucleic Acid Detection Based on RPA/CRISPR (2025 · Advanced Science · 被引 30)
• Synergizing Nanosensor-Enhanced Wearable Devices with Machine Learning for Precision Health Management Benefiting Older Adult Populations (2025 · ACS Nano · 被引 29)
• E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression (2025 · Gut · 被引 28)